Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Parkinson's Disease

Free Subscription 26.05.2025 2 BMC Neurol 2 Brain Res 1 Int J Neurosci 1 J Neural Transm (Vienna) 5 Mov Disord 1 Neurosci Lett 2 Neuroscience 1 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. ALKADUHIMI N, Kerst Y, Vlaar A, Berendse H, et al
   Validation of the Dutch version of the King's Parkinson's disease pain scale.
   BMC Neurol. 2025;25:214.
   PubMed         Abstract available
   
   
2. CHEN Y, Li Y, Huang J, Cai Y, et al
   Comparative study of nonmotor symptoms in progressive supranuclear palsy and Parkinson's disease.
   BMC Neurol. 2025;25:213.
   PubMed         Abstract available
   
   

   
   Brain Res

3. KATRIB C, Naidji C, Devos D, Timmerman K, et al
   Texture features of T2w magnetic resonance imaging mirror tissue changes in Parkinson's disease models.
   Brain Res. 2025 May 19:149717. doi: 10.1016/j.brainres.2025.149717.
   PubMed         Abstract available
   
   
4. CHEN H, Ding H, Huang D, Wu S, et al
   GBE1 alleviates MPTP-induced PD symptoms in mice by enhancing glycolysis and oxidative phosphorylation.
   Brain Res. 2025;1859:149663.
   PubMed         Abstract available
   
   

   
   Int J Neurosci

5. LI T, Wang J, Gao G, Tao B, et al
   Association of SCN2A single nucleotide polymorphisms with Parkinson's disease: Evidence from a case-control Study.
   Int J Neurosci. 2025 May 19:1-16. doi: 10.1080/00207454.2025.2501651.
   PubMed         Abstract available
   
   

   
   J Neural Transm (Vienna)

6. BOUGEA A, Colosimo C, Falup-Pecurariu C, Palermo G, et al
   Fluid biomarkers in atypical Parkinsonism: current state and future perspectives.
   J Neural Transm (Vienna). 2025 May 20. doi: 10.1007/s00702-025-02930.
   PubMed         Abstract available
   
   

   
   Mov Disord

7. WALSHE M, Hirschwald J, Warnecke T
   Measuring What Matters in Parkinson's Disease Research and Dysphagia: The Need for Core Outcome Sets.
   Mov Disord. 2025 May 23. doi: 10.1002/mds.30241.
   PubMed        
   
   
8. VAZIRIAN F, Tian J, Cicuttini F, Jones G, et al
   Reply to: "Chronic Pain and Parkinson's Disease: Causation or Confounding?".
   Mov Disord. 2025 May 23. doi: 10.1002/mds.30234.
   PubMed        
   
   
9. XU QH, Wang YL, Zhang BR, Tian J, et al
   Chronic Pain and Parkinson's Disease: Causation or Confounding?
   Mov Disord. 2025 May 23. doi: 10.1002/mds.30235.
   PubMed        
   
   
10. VAN LAAR AD, Christine CW, Phielipp N, Larson PS, et al
    Intraputaminal Delivery of Adeno-Associated Virus Serotype 2-Glial Cell Line-Derived Neurotrophic Factor in Mild or Moderate Parkinson's Disease.
    Mov Disord. 2025 May 20. doi: 10.1002/mds.30193.
    PubMed         Abstract available
    
    
11. GAN-OR Z, Alcalay RN
    LRRK2-Associated Parkinson's Disease: Is it a Synucleinopathy After All?
    Mov Disord. 2025 May 19. doi: 10.1002/mds.30228.
    PubMed        
    
    

    
    Neurosci Lett

12. CORTES-ALTAMIRANO JL, Alfaro-Rodriguez A, Morraz-Varela A, Reyes-Long S, et al
    Changes in gene expression of D2 and D5 receptors in the thalamus and midbrain caused by a persistent painful stimulus in Parkinsonian rats.
    Neurosci Lett. 2025;859-861:138270.
    PubMed         Abstract available
    
    

    
    Neuroscience

13. QIN K, Liu Y, Xue L, Li H, et al
    Resting-state fMRI study on male patients with Parkinson's disease and with sexual dysfunction.
    Neuroscience. 2025 May 19:S0306-4522(25)00392.
    PubMed         Abstract available
    
    
14. GLASBAUER ND, Sookoian S, Pirola CJ
    Identifying molecular pathways of olfactory dysfunction in Parkinson's disease through a systems biology framework.
    Neuroscience. 2025 May 19:S0306-4522(25)00393.
    PubMed         Abstract available
    
    

    
    PLoS One

15. GORENFLO MP, Gao Z, Davis PB, Kaelber D, et al
    Amphetamine use and Parkinson's disease: integration of artificial intelligence prediction, clinical corroboration, and mechanism of action analyses.
    PLoS One. 2025;20:e0323761.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

16. 
    Correction for Masliah et al., beta-Amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.
    Proc Natl Acad Sci U S A. 2025;122:e2509530122.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.